Global, regional and national burden of pancreatic cancer, 1990 to 2017: Results from the Global Burden of Disease Study 2017

Pancreatology - Tập 20 - Trang 462-469 - 2020
Xiang Chen1, Bin Yi2, Zhongtao Liu1, Heng Zou1, Jiangjiao Zhou1, Zijian Zhang1, Li Xiong1, Yu Wen1
1Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
2Department of Cardiothoracic Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

Tài liệu tham khảo

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J Clin, 68, 394, 10.3322/caac.21492 Ilic, 2016, Epidemiology of pancreatic cancer, World J Gastroenterol, 22, 9694, 10.3748/wjg.v22.i44.9694 2018, Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1684, 10.1016/S0140-6736(18)31891-9 2018, Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1736, 10.1016/S0140-6736(18)32203-7 2018, Lancet, 392, 1923, 10.1016/S0140-6736(18)32225-6 2018, Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1859, 10.1016/S0140-6736(18)32335-3 2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7 Foreman, 2012, Modeling causes of death: an integrated approach using CODEm, Popul Health Metrics, 10, 1, 10.1186/1478-7954-10-1 Gao, 2012, Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005, Eur J Epidemiol, 27, 39, 10.1007/s10654-011-9636-8 Liu, 2019, The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention, J Hepatol, 70, 674, 10.1016/j.jhep.2018.12.001 Fitzmaurice, 2018, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study, Jama Oncol, 4, 1553, 10.1001/jamaoncol.2018.2706 Korc, 2017, Tobacco and alcohol as risk factors for pancreatic cancer, Best Pract Res Clin Gastroenterol, 31, 529, 10.1016/j.bpg.2017.09.001 Liao, 2015, Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis, BMJ, 350, g7371, 10.1136/bmj.g7371 Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Canc, 136, E359, 10.1002/ijc.29210 Raimondi, 2009, Epidemiology of pancreatic cancer: an overview, Nat Rev Gastroenterol Hepatol, 6, 699, 10.1038/nrgastro.2009.177 Lucas, 2016, Global trends in pancreatic cancer mortality from 1980 through 2013 and predictions for 2017, Clin Gastroenterol Hepatol, 14, 1452, 10.1016/j.cgh.2016.05.034 Wong, 2017, Global temporal patterns of pancreatic cancer and association with socioeconomic development, Sci Rep, 7, 3165, 10.1038/s41598-017-02997-2 Maisonneuve, 2015, Risk factors for pancreatic cancer: a summary review of meta-analytical studies, Int J Epidemiol, 44, 186, 10.1093/ije/dyu240 Iodice, 2008, Tobacco and the risk of pancreatic cancer: a review and meta-analysis, Langenbeck’s Arch Surg, 393, 535, 10.1007/s00423-007-0266-2 Ng, 2014, Smoking prevalence and cigarette consumption in 187 countries, 1980-2012, J Am Med Assoc, 311, 183, 10.1001/jama.2013.284692 Maisonneuve, 2019, Epidemiology and burden of pancreatic cancer, Presse Med, 48, e113, 10.1016/j.lpm.2019.02.030 Zhang, 2018, Challenges in diagnosis of pancreatic cancer, World J Gastroenterol, 24, 2047, 10.3748/wjg.v24.i19.2047 Gaujoux, 2019, Pancreatic cancer is still waiting for the big leap forward, Presse Med, 48, e111, 10.1016/j.lpm.2019.02.013 Bouzbid, 2018, Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries, Lancet, S553487375